These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17086997)

  • 1. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing HIV/AIDS patients.
    Paul SM; Sensakovic J; Podhurst LS; Morgan DH; Triano-Davis W
    N J Med; 1998 May; 95(5):55-60. PubMed ID: 16013158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.
    Jones R; Gazzard B
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
    Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumour effects of antiretroviral therapy.
    Monini P; Sgadari C; Toschi E; Barillari G; Ensoli B
    Nat Rev Cancer; 2004 Nov; 4(11):861-75. PubMed ID: 15516959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in the fight against AIDS.
    Godwin C
    RN; 2004 Apr; 67(4):46-52; quiz 53. PubMed ID: 15132046
    [No Abstract]   [Full Text] [Related]  

  • 11. Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.
    Müller AD; Myer L; Jaspan H
    Clin Infect Dis; 2009 Jan; 48(1):e3-5. PubMed ID: 19025495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Options in HIV therapy: present and future].
    Röling J; Draenert R; Goebel FD
    Internist (Berl); 2005 Aug; 46(8):892-4, 896-8. PubMed ID: 15968521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in the treatment of HIV infection/AIDS].
    Matsushita S
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1033-9. PubMed ID: 10431574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid scaling-up of access to antiretroviral therapy in Mexico: Is it better not to treat?
    Volkow P; Villasis A; Cornejo P; Sierra-Madero J
    AIDS; 2007 Jan; 21(2):261-2. PubMed ID: 17197827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy 2006: pharmacology, applications, and special situations.
    Samuel R; Bettiker R; Suh B
    Arch Pharm Res; 2006 Jun; 29(6):431-58. PubMed ID: 16833010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of HIV-associated neuropathy.
    Gonzalez-Duarte A; Robinson-Papp J; Simpson DM
    Neurol Clin; 2008 Aug; 26(3):821-32, x. PubMed ID: 18657728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.